8-K
filed November 14, 2024, 6:59 PM ET
ticker CDT
CIK 0001896212
other material
confidence high
sentiment negative
materiality 0.40
Conduit Pharmaceuticals restates Q1 and Q2 2024 financials; reclassifies deferred commission to current liability
CDT Equity Inc.
- Previously issued unaudited financials for Q1 and Q2 2024 should no longer be relied upon due to reclassification error.
- Restatement reclassifies deferred commission payable from long-term to current liability; no impact on total liabilities.
- Company will file amendments to its Q1 and Q2 2024 Forms 10-Q to correct the balance sheet classification.
- Discussions with auditor Marcum LLP and Audit Committee led to the non-reliance determination on November 12, 2024.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-24-046068
- form_type
- 8-K
- ticker
- CDT
- cik
- 0001896212
- company_name
- CDT Equity Inc.
- filed_at
- 2024-11-14T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:10.291821+00:00
- generated_at
- 2026-05-30T00:39:05.454773+00:00
- sec_items
- ["4.02"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-24-046068
- json_url
- https://secwatch.observer/filing/0001493152-24-046068.json
- markdown_url
- https://secwatch.observer/filing/0001493152-24-046068.md
- text_url
- https://secwatch.observer/filing/0001493152-24-046068.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1896212/000149315224046068/0001493152-24-046068-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1896212/000149315224046068/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GCGJ
Guochun International (GCGJ) restates Sep 2025 financials; $8,250 error in G&A expenses
GUOCHUN INTERNATIONAL INC.
March 26, 2026, 7:59 PM ET
other_material
Items 4.02
same SEC item: 4.02
same event type: other_material
similar materiality
Filing page
SEC filing
RITE
MineralRite restates financials, cuts asset carrying value from $432M to $246M
MINERALRITE Corp
May 27, 2026, 4:02 PM ET
other_material
Items 4.02, 7.01, 8.01, 9.01
same SEC item: 4.02
same event type: other_material
Filing page
SEC filing
GWLL
Goldenwell Biotech to restate three quarterly reports over $9,840 legal fee timing errors
GOLDENWELL BIOTECH, INC.
May 26, 2026, 8:17 PM ET
other_material
Items 4.02, 9.01
same SEC item: 4.02
same event type: other_material
Filing page
SEC filing
SPTY
Specificity to restate 2025 10-K after identifying accounting errors in Dec 2025
SPECIFICITY, INC.
May 22, 2026, 9:41 PM ET
other_material
Items 4.02
same SEC item: 4.02
same event type: other_material
Filing page
SEC filing
NMTC
NeuroOne restates Q1 FY2026 results due to revenue recognition error; reaffirms FY2026 guidance
NEUROONE MEDICAL TECHNOLOGIES Corp
May 22, 2026, 4:30 PM ET
other_material
Items 4.02, 7.01, 9.01
same SEC item: 4.02
same event type: other_material
Filing page
SEC filing
BGFR
BestGofer restates Q1 FY2026; goodwill impairment of $78,754 increases net loss to $85,755
BestGofer Inc.
May 19, 2026, 5:26 PM ET
other_material
Items 4.02, 2.06
same SEC item: 4.02
same event type: other_material
Filing page
SEC filing
ZONE
CleanCore Solutions restates Q3 2026 financials; 70M Dogecoin transfer error
CleanCore Solutions, Inc.
May 18, 2026, 4:30 PM ET
other_material
Items 4.02
same SEC item: 4.02
same event type: other_material
Filing page
SEC filing
CGC
Canopy Growth restates FY2024-2025 financials due to warrant classification error; Q4/FY2026 results delayed to June 15
Canopy Growth Corp
May 15, 2026, 5:06 PM ET
other_material
Items 4.02, 7.01, 9.01
same SEC item: 4.02
same event type: other_material
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.